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Abstract
Histologicalstudieshavedemonstratedthatpolycysticovaries(PCO)containincreasednumbersofpreantralfollicleswithaspeciﬁcincrease
in primary follicles. Polycystic ovary syndrome is associated with hyperandrogenism and pre- and postnatal androgenisation of primates
increasesthepoolofgrowingfolliclesproducingchangesresemblingPCO.Invitrostudiescouldtestthehypothesisthatandrogensalterearly
folliculogenesis, but conventional culture techniques for small follicles are generally unsuitable in non-rodent species. Our objective was to
develop and use a method to investigate the effects of testosterone on early folliculogenesis. We adapted an in ovo technique in which lamb
cortical ovarian fragments were grafted onto the chorioallantoic membrane offertilised chick eggs. Optimal experimental conditions for
vascularisation and survival of tissue were determined and the model then used to investigate the effects of testosterone on follicle growth.
Eggswereinoculatedwithtestosteroneatthetimeofimplantationoftheovariantissue,whichwasretrieved5dayslater.Tissuewassectioned
andfolliclesstagedandcounted.Therewasnowholesaleinitiationofprimordialfolliclegrowthoverthe5-dayinovoculture.Importantly,the
proportionofprimordial,primaryandsecondaryfolliclesremainedsimilartothoseinunimplantedtissue.Testosteroneincreasedthenumber
of primary follicles by 50% compared with controls, an effect that was largely due to a reduction in atresia. In conclusion, incubation of
ovarian cortex with testosterone reproduces the changes in early folliculogenesis reported in histological studies of PCO.
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Introduction
Polycystic ovaries (PCO) are present in w20% of the
femalepopulationofreproductiveage(Polsonetal.1988,
Farquhar et al. 1994, Michelmore et al. 1999). These
ovaries are enlarged and diagnosed by the increased
numberoffolliclesorcystsattheantralstage(Adamsetal.
1985). It is becoming clear, however, that the increase in
follicle number actually occurs during preantral follicu-
logenesis. Until recently, there was only one publication
that quantiﬁed this increase and that reported an
approximate doubling of each of the growing stages of
follicle and twice as many atretic follicles in PCO as in
normal ovaries (Hughesdon 1982). Recently, two further
studieshavebeenaddedsigniﬁcantlytothisarea.Theﬁrst
study, utilising ovarian biopsies, found approximately six
times as many preantral follicles in PCO as in normal
ovariesandaparticularincreaseinfolliclesattheprimary
stage (Webber et al. 2003). The ﬁndings of the second
study counting follicles in ﬁxed slices of whole ovary
conﬁrmed that ‘stockpiling’ of follicles occurred at the
primary stage (Maciel et al. 2004).
The cause of this speciﬁc increase in primary follicles is
unknown; however, there are a number of lines of
evidence pointing to the raised androgens that are a
diagnostic feature of polycystic ovary syndrome (PCOS;
Gilling-Smith et al.1 9 9 4 , Nelson et al.1 9 9 9 ) as the most
likely agent. In primates, in vivo androgen treatment
induced multiple ovarian cysts and increased the number
ofsmallfollicles(Vendola etal.1998),whereasinprimates
and sheep, prenatal androgenisation also produced off-
spring with ovaries containing multiple antral follicles
(Abbott et al.2 0 0 2 ). Intrinsic androgen overproduction in
humans from causes such as congenital adrenal hyperpla-
sia induces PCO (Padmanabhan et al. 1998, Merke et al.
2002) and laboratory animals treated with androgens
develop cystic ovaries (Beloosesky et al. 2004, Tamura
et al. 2005). Finally, an association between serum
androgen concentration and ovarian follicle numbers in
humans has also been demonstrated (Franks et al. 1995,
Battagliaetal.2000).Together,theseﬁndingsprovidegood
indirect evidence that androgens cause changes in
folliculogenesis that are characteristic of PCO.
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gating the effects of androgens on primate follicles grown
in culture, largely due to the methodological problems of
wholesale activation of primordial follicles and high
rates of atresia. In 2002, Fortune et al. described the
implantation of foetal bovine ovarian cortical pieces
‘under’ the chorioallantoic membrane (CAM) of chick
embryos (Cushman et al. 2002). They reported that this
in ovo culture procedure did not result in wholesale
initiation of primordial follicular growth. The aim of our
study was to adapt this technique to examine the
hypothesis that testosterone is responsible for the speciﬁc
increase in primary follicles seen in PCO. We report the
conditions required to permit follicle survival inpieces of
prepubertal lamb ovarian cortex grafted onto the CAM of
fertilised chicken eggs, the fate of follicles grafted in this
way and the effects of in ovo testosterone exposure on
follicle growth and survival.
Results
Factors affecting embryonic chick survival
and vascularisation of implanted ovarian tissue
In establishing this method, conditions were optimised
for embryonic chick survival and hence vascularisation
of implanted ovarian tissue. Initial experiments
determined that important determinants were the length
of the pre-incubation period and the time for which the
egg was out of the incubator i.e. during the windowing
and implanting procedures. Survival dropped from 60%
at 2 days of storage to less than 20% at 17 days.
The highest survival (more than 50%) was seen when the
total operative procedure was less than 3 min and this
fell to 20% when 7 min or more were taken.
Embryonic survival and tissue vascularisation in eggs
containing surviving embryonic chicks using ‘dropped’
versus ‘wedged’ techniques were 63% (nZ30) and 50%
(nZ20) vs 50% (nZ14) and 86% (nZ7) respectively.
There were no signiﬁcant differences in these parameters
(c
2); however, wedged tissue proved easier to retrieve and
was therefore adopted. Non-vascularised tissue was
generally located away from the CAM region (albumen,
yolksac,etc).Tissuethathadbecomeencapsulatedbythe
CAM contained obvious blood vessels (Fig. 1A–E). The
optimised procedure resulted in a mean embryo survival
per experiment of 52% and of these 46% contained
well-vascularised tissue (nZ100 eggs).
Folliculogenesis in ovarian cortical fragments cultured
in ovo for 5 days
Healthy follicles at all stages were seen in vascularised
tissue although secondary follicles were rare (Fig. 1F–I).
In the histological sections, nucleated chick blood cells
could be seen inﬁltrating the lamb tissue. The percentage
of primordial, primary and secondary follicles in cortical
fragments implanted onto the CAM for 5 days was 69,
14.5 and 1.6 respectively and this was similar to the
unimplanted baseline fragments in which the corre-
sponding percentages were 76, 14.6 and 0.8 respec-
tively. In total, 840 follicles (both healthy and atretic)
were counted. Thus, the mean percentage of primordial
follicles dropped by 10.3%, the mean percentage of
primary follicles was unchanged and there was a
doubling of secondary follicles in tissue cultured
in ovo. Thesedifferenceswerenotstatisticallysigniﬁcant.
The percentage of atretic follicles in well-vascularised
cortical tissue was double that in unimplanted tissue;
15% vs 8.4% (PZ0.002).
Effects of testosterone
Testosterone was found to disperse rapidly throughout
the compartments of the egg and although not evenly
distributed large amounts were available in the CAM
throughout the 5 days of experimentation. For the
experiment on the effects of testosterone on follicle
growth, of the 100 pieces implanted from two lambs, 24
vascularised pieces were retrieved and 14 of these were
considered very well or well vascularised and processed
further. Final numbers were three for each of the
implanted control and testosterone-treated groups and
four for each of baseline unimplanted, FSH- and
testosterone and FSH-treated groups. There were no
signiﬁcant differences in vascularisation rates between
different treatments (Mann–Whitney test).
A total of 2773 follicles were imaged; 275 follicles
were classed as ungradable, in that they were of
insufﬁcient quality to permit accurate visualisation of
follicular features. The number of tissue pieces and
number and percentage of follicles of each stage are
shown in Table 1. The number offollicles of each stage is
the total number in all tissue pieces within a treatment
group. The respective percentage is the weighted mean
of the percentage data calculated from each individual
tissue piece.
Each of the hormone treatments caused a selective
increase in the proportion of primary follicles. The
proportion of primary follicles was 50% higher in the
testosterone-treated group than in the implanted control:
21 vs 14%, P!0.01 (Fig. 2). The addition of FSH
produced similar results (48% increase PZ0.01) and the
addition of testosterone and FSH together had an even
greater effect with a 74% increase (P%0.001). There
was no change in the proportion of secondary follicles
in tissue exposed to FSH, but there was a reduction
in follicles of this stage in both groups exposed to
testosterone. This difference was not signiﬁcant,
however, because of the wide range. Interestingly,
there was a signiﬁcant fall in the percentage of atretic
follicles in both groups in which testosterone was added:
15% to 5.6 and 6.7% for testosterone alone and
testosterone with FSH respectively. Both reductions
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was no signiﬁcant change in the rate of follicle atresia in
those pieces exposed to FSH alone.
Discussion
The ﬁrst use of the CAM technique may have been as
early as 1911, but it had clearly been used by several
investigators by the 1920s and 1930s (Burnet 1933). It
has been used by embryologists for many years
(Rawles 1952) and more recently was adopted to
study the factors involved in angiogenesis (Ribatti et al.
1996, Brooks et al.1 9 9 9 , Storgard et al. 2005). There
have been two reports describing the use of the CAM
technique for studying early folliculogenesis in foetal
bovine tissue (Fortune et al. 2000, Cushman et al.
2002). The authors did not, however, provide a
detailed analysis of the optimal conditions required
for successful vascularisation or data regarding success
rates of this technique. Our interest in mechanisms
controlling early folliculogenesis, particularly in
relation to PCO, led us to investigate the potential
use of this technique in non-foetal tissue. Our initial
studies were carried out in human cortex but we
found, similar to others (Schmidt et al. 2003), that the
density of follicles in typical patients undergoing
oophorectomy was too low to be of practical use and
we changed to using lamb ovaries.
Figure 1 (A–E) Variation in macroscopic vascularisation of tissue recovered 5 days after implantation. Figures in parentheses indicate the frequency
with which each degree of vascularisation was found. (A) Non-vascularised tissue usually retrieved from the albumen or yolk or on the shell or
vitelline membranes or amnion (24%). (B) Poorly vascularised tissue encapsulated by the CAM with obvious blood vessels but ovarian tissue pale in
colour(18%).(C) Partly-vascularised tissuethatwas pinkinisolatedareas (22%).(D) Well-vascularised tissue thatwas mostlypink(28%)and (E)very
well-vascularised tissue that was pink throughout (8%). (F–I) Histological sections of a primordial (F), primary (G) and secondary(H) follicles in lamb
ovarian cortical tissue cultured using the CAM technique. Nucleated chick red blood cells (arrows) are clearly seen inﬁltrating the ovarian tissue. An
atretic follicle is illustrated in (I).
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technique and from the early stages it was apparent that
cortical fragment vascularisation was completely depen-
dent upon chick embryo survival with both the duration
of the pre-incubation storage and the operative
procedure being important determinants. Increased
embryonic death in relation to the duration of egg
exposure to the air is likely to be due to dehydration and
a lethal drop in temperature.
In vascularised tissue, there was evidence of extensive
invasion or anastomosis by chick vessels, even after only
5 days. Cushman et al. (2002) also reported that, when
successful, vascularisation was evident within 2 days of
implantation of foetal bovine cortical slices and was
extensive after 10 days. In contrast to these experiments,
their pieces of implanted ovarian cortex were very
small, i.e., 0.5 mm
3. We inserted larger pieces because
vascularisation was equally as good and these were
more readily retrieved and visualised.
A number of approaches have been used to attempt to
culturebothfolliclesandwholeovariesandalthoughthere
has been some success with murine tissue (Blandau et al.
1965,Eppig&O’Brien1996),bovineandprimatecortical
slices have proven more difﬁcult. There were two main
problems makingthesemethods unsuitabletoaddress our
hypothesis. The ﬁrst was the synchronous activation of the
majority of resting (primordial) follicles, which was
mirroredbyamassiveincreaseinprimaryfollicles(Fortune
et al.2 0 0 0 ) within the ﬁrst day. This is very different from
the more gradual activation of primordial to primary
follicles occurring in vivo. Similarly, wholesale activation
of primordial follicles was reported in cortical slices of
adultbovine(Braw-Tal&Yosseﬁ1997)andhumanovarian
cortical slices (Hovatta et al. 1997) and the techniques are
Table 1 Numbers of embryos and well-vascularised pieces of tissue retrieved and used for comparison. In the ﬁrst two columns, the ﬁgures in
parentheses show the percentages. The last four columns show the total number of follicles found of each stage for each treatment. Numbers in
parentheses show straight and weighted percentages.
Treatment
Number of
surviving embryos
(%)
Number of tissue
pieces well vascu-
larised (%)
Number of
primordial follicles
(%/weighted %)
Number of
primary follicles
(%/weighted %)
Number of
secondary follicles
(%/weighted %)
Number of atretic
follicles
(%/weighted %)
Unimplanted 401 (74/76) 77 (15/15) 4 (1/1) 44 (11/8)
Implanted control 13 (52) 3 (50) 266 (68/69) 56 (15/15) 6 (2/2) 58 (15/15)
Testosterone 13 (52) 3 (60) 575 (56/73) 158 (22/20) 6 (1/1) 44 (22/6)
TestosteroneCFSH 14 (56) 4 (67) 302 (59/67) 114 (30/25) 5 (2/1) 30 (10/7)
FSH 12 (48) 4 (57) 62 (230/65) 76 (23/22) 6 (4/2) 40 (13/11)
Figure 2 The proportion of atretic and healthy
follicles of different stages in each group of
baseline or implanted pieces of tissue
(weighted meanGS.E.M.). There was a signi-
ﬁcant decrease in the proportion of primor-
dial follicles and an increase in atresia when
tissue was implanted (PZ0.014 and 0.002
respectively). The proportion of primary
follicles was increased in those pieces
exposed to androgen in the absence
(PZ0.019) or presence (P!0.001) of FSH.
There was a highly signiﬁcant corresponding
reduction in atresia in each case (P!0.001).
FSH also increased primary follicle numbers
(PZ0.013), but there was no change in the
proportion of atretic follicles with this
hormone.
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CAM method, there was no wholesale transition of
primordial to primary follicles and the proportion of
primordial, primary and secondary follicles remained
largely unchangedwith culture aswas found by Cushman
etal.(2002).Notsurprisingly,wedidseeanincreaseinthe
proportion of atretic follicles when tissue was implanted.
The second problem with previous culture methods
was the large number offollicles that became atretic. It is
not uncommon for half of cultured follicles to be lost due
to atresia using such techniques (Wandji et al. 1996). We
were concerned that rapid initiation and a high rate of
atresia may mask changes produced by androgens and
therefore, although laborious, we considered the CAM
method the most suitable to address our hypothesis. The
rate of atresia that we have seen in our tissue, even using
our strict criteria, was even lower than that reported
by other groups using this technique (Wandji et al. 1996,
Cushman et al. 2002), but this may be partly due to
the fact that other studies were performed using foetal
tissue in which the basal rate of follicle death is likely to
be higher.
Using this technique, we have demonstrated that
exposure to testosterone selectively increased the
proportion of follicles at the primary stage. In other
words, we have reproduced the ﬁndings of studies
counting follicles in biopsies and slices of PCO. Our data
add considerable weight to the hypothesis that andro-
gens cause the alteration in early follicle development
seen in PCO. Our data indicate that the most likely
explanation for this is that testosterone reduced the
number of follicles undergoing atresia. These data
contrast with those of both Hughesdon (1982) and
Webber et al. (2003) who found no change in the
proportion of atretic follicles in cortical biopsies or slices
from PCO. In a more recent study, however, it was
discovered that cultured follicles from PCO survived to a
much greater extent than those from normal ovaries and
thiswas due to reduced atresia (Webber et al. 2007). Our
data suggest a possible mechanism for this effect.
It remains to be determined whether androgens are
also having a direct effect on follicle growth or are
modulating the levels of local or endocrine factors.
To date, neither androgen nor FSH receptors have been
demonstrated in primordial follicles of sheep or human
follicles, but in sheep androgen receptor protein was
present in type-2 follicles, equivalent to our primary and
primary–secondary transitional follicles (Juengel et al.
2006) and in isolated human follicles, 18% of transi-
tional follicles and 43% of primary follicles expressed
testosterone receptors (Rice et al. 2007) suggesting that
there might be a direct effect on atresia by androgen in at
least this proportion of follicles. It is possible that
exposure to androgens could increase the number of
androgen receptor-positive follicles, but we have not yet
determined this.
Our data show that follicle-stimulating hormone (FSH)
also altered the proportion of primary follicles. While
many studies have demonstrated preantral folliculogen-
esis in the absence of gonadotrophins, FSH receptors are
present on early follicles and FSH may therefore be
exerting an effect (Oktay et al. 1997, Rice et al. 2007),
although the percentage of follicles expressing this
receptor is very low. Interestingly, there was no
signiﬁcant effect of FSH on follicle atresia in our
experiments and the increase in primary follicles appears
to come from increased initiation as there was a fall in
primordial follicles, although this was not signiﬁcant.
This supports the ﬁndings of an earlier paper in which
FSH was found to promote preantral follicle growth
in rats without having an effect on apoptosis (McGee
et al. 1997).
Very few of the fundamental genes involved in early
folliculogenesis have been identiﬁed; nevertheless some
abnormalities have been shown in PCO. GDF9, for
example, is implicated in early follicle growth and
whereas in normal human ovaries GDF9 was detected in
32% of oocytes in primordial follicles and 96% of
primary follicles, in PCO, GDF9 mRNAwas not detected
in primordial follicles and was present in less than 12%
of primary follicles (TeixeiraFilhoet al. 2002). The effects
of androgens on GDF9 expression are, however,
unknown but this promises to be a fruitful area for future
research.
Although higher in the serum of women with PCOS
(Cook et al. 2002, Laven et al. 2004), the foetal
differentiative factor AMH was present at a lower
frequency in primordial and transitional follicles in
these ovaries on immunostaining (Stubbs et al. 2005).
AMH-knockout mice have increased follicle initiation
and follicles progress rapidly through the early stages of
folliculogenesis (Durlinger et al. 1999). Low levels of
AMH in PCO could therefore produce the same effect.
The effects of androgens on the production of this factor
are, however, also unknown.
One disadvantage of the CAM method is that factors
produced by the embryo itself may effect the growth
offollicles in the implanted cortex. For example, Fortune
et al. elegantly demonstrated that chick AMH inhibited
follicle growthin this model by showingthat, unliketheir
early experiments, growth did occur in tissue grafted
from mice null mutant for the AMH type II receptor
(Gigli et al. 2005). In our experiment, it was assumed
that if implanted tissue was indeed exposed to chick
AMH that this would be likely to affect all treatment
groups equally.
In conclusion, we have shown that the method
ﬁrst adopted by Fortune et al. (2000) for investigating
folliculogenesis in fragments of bovine embryo ovaries
can be applied to lamb ovarian tissue. In addition, our
studies have carefully deﬁned the conditions under
which successful vascularisation of cortical tissue
occurs. Unlike classical methods of in vitro culture,
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primordial to primary follicles. Exposure of the tissue in
this model to testosterone, with or without FSH, caused a
selective increase in the proportion of primary follicles
reproducing the ﬁndings from key histological studies in
PCO. Androgens are implicated in many of the
manifestations of PCOS; reprogramming the HPO axis,
the tendency to central adiposity and the insulin
resistance. Now there is very good evidence that they
are also responsible for the earliest follicular abnormal-
ities seen in PCO. Elucidating the underlying cause of
excess androgen production by these ovaries would
appear to be of primary importance.
Materials and Methods
Development and characterisation of the CAM method
Fertilised eggs from White Leghorn chickens (Henry Stewart
and Co. Ltd, Louth, Lincolnshire, UK) were kept at 12 8C for
0–17 days until required. Preliminary experiments investigated
the effect of the length of time of pre-incubation on chick
embryonic survival. Prior to implantation of ovarian tissue,
eggs were transferred for 5 days to an incubator at 37–38 8C
and relative humidity of 55–60% to permit foetal growth and
development of the CAM. Both human and lamb cortical
tissues were used while establishing the technique. Human
ovarian tissue was collected with ethical approval and
informed consent from ﬁve patients ranging in age from 36 to
46 years. The human tissue contained too few follicles to be
experimentally useful. Lamb ovarian tissue from animals less
than 1-year old was obtained from a local abattoir. Ovarian
cortical fragments of w1!2!8 mm were dissected from lamb
or human ovaries within 1 h of arrival in the laboratory. For
baseline data, two fragments were ﬁxed immediately in 4%
paraformaldehyde.
The embryo, air sac and CAM were visualised through the
eggshell using a ﬁber-optic light (‘candling’); the CAM and the
air sac marked with a pencil and a small drill used to excise a
triangular piece of shell of 8!8!8 mm over the CAM
(‘windowing’). A 5 mm slit was made in the underlying shell
membrane through which the ovarian tissue was implanted.
Although Cushman et al. (2002) reported insertion of tissue
beneath the CAM, we found that this wasimpossible to perform
without puncturing the CAM with resultant death of the
embryo. A preliminary series of experiments determined
optimum conditions. Lamb ovarian fragments were either
dropped onto the CAM or ﬁxed more ﬁrmly by wedging the
tissue in the junction between the shell membrane and the
CAM. The window was sealed with transparent adhesive tape
and the eggs returned to the incubator. The effect of the time
taken to candle, window the egg and implant the tissue on
survival of the embryo was also assessed.
After 5 days the tissue was retrieved. Tissue encapsulated by
the CAM and containing blood vessels was graded for
vascularity from poorly vascularised, which appeared pale, to
very well vascularised, in which the entire fragment was pink.
After dehydration and wax embedding, serial sections 5–6 mm
were cut and stained with haematoxylin and eosin, visualised
with a Zeiss microscope and the images captured with a Nikon
DXM1200 digital camera (Nikon, Kingston-upon-Thames, UK)
and LUCIA image analysis software (Nikon, version 2.62).
Only follicles with a visible nucleolus were included to avoid
duplicate counting.
Classifying follicular development and atresia
Primordial, primary and secondary follicles were classiﬁed
according to the method of Wright et al. (1999). Atretic follicles
were identiﬁed by the presence of one or more pyknotic nuclei
of the granulosa cells and/or the nucleus of the oocyte.
It became clear in the early stages that tissue that was poorly
vascularised contain high proportions of atretic follicles and
therefore only well- and very well-vascularised tissues were
processed in further experiments.
Effects of testosterone treatment
Initially, the distribution of testosterone within the compart-
ments of the egg was assessed by the addition of 10 ml tritiated
testosterone (Amersham Biosciences, 9 MBq/ml) to each of 20
eggs. At 24 h intervals for the next 5 days, four eggs were
broken into separate dishes and from each 250 ml of each of the
following were collected: yolk, albumen, CAM cavity ﬂuid,
CAM, vitelline membrane and embryo. Tissues were macer-
ated, spun and the supernatant aspirated. These were added to
4 ml scintillation ﬂuid and the activity counted (LS 6000IC,
Beckman Coulter, Buckinghamshire, UK).
For the testosterone treatment experiments, 50 eggs were
implanted with pieces of ovarian cortex from one lamb. This
experiment was performed twice. Follicles in tissue from
ﬁve groups were counted: baseline unimplanted tissue and four
groups of implanted tissue; control, testosterone treated, FSH
treatedandtissueexposedtobothtestosteroneandFSHtogether.
Testosteroneataﬁnalconcentrationinthe egg(48 mlvolume)of
10
K7M(SigmaChemicalCo.)and/orFSHat0.04 IU/ml(8 ng/ml;
puriﬁed human pituitary, Endocrine Services, Bidford-On Avon,
UK) were added in 10 ml medium through the slit in the shell
membrane at the time of implantation. For control implanted
tissue, 10 ml medium alone was added. The window was sealed
withSellotapeandtheeggsreturnedtotheincubatorforafurther
5 days after which the tissue was retrieved and processed as
outlined above.
Statistical analysis
To assess the rate of atresia and the degree of follicle initiation,
840 follicles were counted. In the testosterone experiments,
2773 follicles were counted. The former represents all the
healthy and atretic follicles counted in serial sections of four
well-/very well-vascularised pieces of tissue and four baseline
controls. For the analysis of the testosterone-treated tissue,
transitional follicles were designated as either primordial or
primary according to whether they had more or less than 50%
cuboidal cells.Due tothe wide rangeoffollicle numberswithin
each cortical section, these data are more meaningfully
analysed by proportion rather than absolute number. To adjust
for the wide range of numbers of follicles in each tissue piece,
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differences between the proportions using binomial regression
allowing for overdispersion, using the blogit command with
robust standard errors in Stata 9 (StataCorp LP, College Station,
TX, USA). Kruskal–Wallis, Mann–Whitney, and c
2-tests were
used for other analyses as indicated in the text.
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